_version_ 1782337823347572736
author Haar, Nienke Ter
Jeyaratnam, Jerold
Anton-Lopez, Jordi
Galeotti, Caroline
Barron, Karyl
Brogan, Paul
Cantarini, Luca
Gattorno, Marco
Grateau, Gilles
Hentgen, Veronique
Hofer, Michael
Kallinich, Tilmann
Kone-Paut, Isabelle
Kümmerle-Deschner, Jasmin
Lachmann, Helen
Ozdogan, Huri
Ozen, Seza
Uziel, Yosef
Wouters, Carine
Feldman, Brian
Vastert, Bas
Wulffraat, Nico
Simon, Anna
Frenkel, Joost
author_facet Haar, Nienke Ter
Jeyaratnam, Jerold
Anton-Lopez, Jordi
Galeotti, Caroline
Barron, Karyl
Brogan, Paul
Cantarini, Luca
Gattorno, Marco
Grateau, Gilles
Hentgen, Veronique
Hofer, Michael
Kallinich, Tilmann
Kone-Paut, Isabelle
Kümmerle-Deschner, Jasmin
Lachmann, Helen
Ozdogan, Huri
Ozen, Seza
Uziel, Yosef
Wouters, Carine
Feldman, Brian
Vastert, Bas
Wulffraat, Nico
Simon, Anna
Frenkel, Joost
author_sort Haar, Nienke Ter
collection PubMed
description
format Online
Article
Text
id pubmed-4184306
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41843062014-10-30 Evidence based recommendations for diagnosis and management of mevalonate kinase defiency (MKD) Haar, Nienke Ter Jeyaratnam, Jerold Anton-Lopez, Jordi Galeotti, Caroline Barron, Karyl Brogan, Paul Cantarini, Luca Gattorno, Marco Grateau, Gilles Hentgen, Veronique Hofer, Michael Kallinich, Tilmann Kone-Paut, Isabelle Kümmerle-Deschner, Jasmin Lachmann, Helen Ozdogan, Huri Ozen, Seza Uziel, Yosef Wouters, Carine Feldman, Brian Vastert, Bas Wulffraat, Nico Simon, Anna Frenkel, Joost Pediatr Rheumatol Online J Poster Presentation BioMed Central 2014-09-17 /pmc/articles/PMC4184306/ http://dx.doi.org/10.1186/1546-0096-12-S1-P73 Text en Copyright © 2014 Haar et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Haar, Nienke Ter
Jeyaratnam, Jerold
Anton-Lopez, Jordi
Galeotti, Caroline
Barron, Karyl
Brogan, Paul
Cantarini, Luca
Gattorno, Marco
Grateau, Gilles
Hentgen, Veronique
Hofer, Michael
Kallinich, Tilmann
Kone-Paut, Isabelle
Kümmerle-Deschner, Jasmin
Lachmann, Helen
Ozdogan, Huri
Ozen, Seza
Uziel, Yosef
Wouters, Carine
Feldman, Brian
Vastert, Bas
Wulffraat, Nico
Simon, Anna
Frenkel, Joost
Evidence based recommendations for diagnosis and management of mevalonate kinase defiency (MKD)
title Evidence based recommendations for diagnosis and management of mevalonate kinase defiency (MKD)
title_full Evidence based recommendations for diagnosis and management of mevalonate kinase defiency (MKD)
title_fullStr Evidence based recommendations for diagnosis and management of mevalonate kinase defiency (MKD)
title_full_unstemmed Evidence based recommendations for diagnosis and management of mevalonate kinase defiency (MKD)
title_short Evidence based recommendations for diagnosis and management of mevalonate kinase defiency (MKD)
title_sort evidence based recommendations for diagnosis and management of mevalonate kinase defiency (mkd)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184306/
http://dx.doi.org/10.1186/1546-0096-12-S1-P73
work_keys_str_mv AT haarnienketer evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT jeyaratnamjerold evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT antonlopezjordi evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT galeotticaroline evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT barronkaryl evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT broganpaul evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT cantariniluca evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT gattornomarco evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT grateaugilles evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT hentgenveronique evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT hofermichael evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT kallinichtilmann evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT konepautisabelle evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT kummerledeschnerjasmin evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT lachmannhelen evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT ozdoganhuri evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT ozenseza evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT uzielyosef evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT wouterscarine evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT feldmanbrian evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT vastertbas evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT wulffraatnico evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT simonanna evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd
AT frenkeljoost evidencebasedrecommendationsfordiagnosisandmanagementofmevalonatekinasedefiencymkd